Origin Agritech CEO Bill Niebur Purchases Treasury Shares from Company

Tuesday, August 8, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

DES MOINES, Iowa, August 8, 2017 /PRNewswire/ -- Origin Agritech Ltd. (Nasdaq: SEED) ("the Company" or "Origin"), an agricultural

biotechnology trait and corn seed provider, today announced that Origin CEO Dr. Bill Niebur has reported the purchase of 73,530 treasury shares from the Company for a total value of $100,000.

The purchase transaction by Dr. Niebur was made on a private placement basis, and consummated on August 7, 2017, at a price of $1.36 per share. The purchase price reflected the market price as of the close of the market on August 4, 2017. The shares are "restricted" securities and do not have registration rights.

About Origin Agritech Ltd.

Origin Agritech Limited, founded in 1997 and headquartered in Zhong-Guan-Cun (ZGC) Life Science Park in Beijing, is China's leading agricultural biotechnology company, specializing in crop seed breeding and genetic improvement, seed production, processing, distribution, and related technical services. Leading the development of crop seed biotechnologies, Origin Agritech's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Over the years, Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits. Origin operates production centers, processing centers and breeding stations nationwide with sales centers located in key crop-planting regions. Product lines are vertically integrated for corn, rice and canola seeds. For further information, please visit the Company's website at: http://www.originseed.com.cn or http://www.originseed.com.cn/en/.

 

View original content:http://www.prnewswire.com/news-releases/origin-agritech-ceo-bill-niebur-purchases-treasury-shares-from-company-300500713.html

SOURCE Origin Agritech Limited



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store